Acticor Biotech
Christelle Lesieur shows a 4.5 years-experience in the pharmaceutical industry. After a role of Formulation Scientist at Sanofi in biologics development, Christelle has been working as CMC Project Manager at IDD, before joining Acticor Biotech in 2022 at the position of Pharmaceutical Development Project Manager. In charge of the drug substance and the drug product manufacturing, she is responsible for the whole manufacturing process of ACT017.
This person is not in any offices
Acticor Biotech
Acticor Biotech is a spin-off from Inserm (French National Institute of Health and Medical Research) dedicated to the development of an innovative therapeutic strategy for safe and effective emergency treatment of ischemic strokes which account for 80% of all strokes.